Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T19:17:42.528Z.
Calculation as of: 2026-10-06T19:17:42.528Z.
Quote observation: 2026-10-06T19:14:43.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c001abb9fb130ee2b6508d8c6936c8922234201b227c8e733dd2d15e066cad3f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Market Cap
$9.72M
EV/Sales Ratio
0.78x
TTM Avg
3.06x
3Y Avg
5.84x
5Y Avg
28.58x
Market Cap
$9.65M
EV/Sales Ratio
1620.41x
TTM Avg
683.01x
3Y Avg
535.46x
5Y Avg
1037.99x
Market Cap
$10.10M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.22M
EV/Sales Ratio
N/A
TTM Avg
52.89x
3Y Avg
52.89x
5Y Avg
52.89x
Market Cap
$8.83M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.37M
EV/Sales Ratio
438.86x
TTM Avg
943.18x
3Y Avg
346.01x
5Y Avg
219.00x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MetaVia Inc. (MTVA) | $9.82M | N/A | N/A | N/A | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.82M | N/A | 87.23x | 46.21x | 94.29x |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.72M | 0.78x | 3.06x | 5.84x | 28.58x |
| Ainos, Inc. (AIMD)vs › | $9.65M | 1620.41x | 683.01x | 535.46x | 1037.99x |
| Lifeward Ltd. (LFWD)vs › | $10.10M | 0.54x | 0.46x | 0.66x | 0.66x |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | N/A | N/A | N/A | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.22M | N/A | 52.89x | 52.89x | 52.89x |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.83M | N/A | N/A | N/A | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.37M | 438.86x | 943.18x | 346.01x | 219.00x |
| Satellos Bioscience Inc. (MSLE)vs › | $10.39M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
